Your browser doesn't support javascript.
loading
Outcome of combination therapy using BRAF and MEK inhibitors among Asian patients with advanced melanoma: An analysis of 112 cases.
Fujisawa, Yasuhiro; Ito, Takamichi; Kato, Hiroshi; Irie, Hiroyuki; Kaji, Tatsuya; Maekawa, Takeo; Asai, Jun; Yamamoto, Yuki; Fujimura, Taku; Nakai, Yasuo; Yasuda, Masahito; Matsuyama, Kanako; Muto, Ikko; Matsushita, Shigeto; Uchi, Hiroshi; Nakamura, Yoshiyuki; Uehara, Jiro; Yoshino, Koji.
Afiliação
  • Fujisawa Y; Department of Dermatology, University of Tsukuba, Japan. Electronic address: fujisan@md.tsukuba.ac.jp.
  • Ito T; Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Japan.
  • Kato H; Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Japan.
  • Irie H; Department of Dermatology, Kyoto University Graduate School of Medicine, Japan.
  • Kaji T; Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.
  • Maekawa T; Department of Dermatology, Jichi Medical University, Japan.
  • Asai J; Department of Dermatology, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Kyoto, Japan.
  • Yamamoto Y; Department of Dermatology, Wakayama Medical University, Japan.
  • Fujimura T; Department of Dermatology,Tohoku University Graduate School of Medicine, Japan.
  • Nakai Y; Department of Dermatology, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
  • Yasuda M; Department of Dermatology, University of Gunma, Japan.
  • Matsuyama K; Department of Dermatology, University of Gifu, Japan.
  • Muto I; Department of Dermatology, Kurume University School of Medicine, Japan.
  • Matsushita S; Department of Dermato-Oncology / Dermatology, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan.
  • Uchi H; Department Dermato-Oncology, National Hospital Organization Kyushu Cancer Center, Japan.
  • Nakamura Y; Department of Dermatology, University of Tsukuba, Japan.
  • Uehara J; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Japan.
  • Yoshino K; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Japan.
Eur J Cancer ; 145: 210-220, 2021 03.
Article em En | MEDLINE | ID: mdl-33503528
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Protocolos de Quimioterapia Combinada Antineoplásica / Quinases de Proteína Quinase Ativadas por Mitógeno / Proteínas Proto-Oncogênicas B-raf / Inibidores de Proteínas Quinases / Melanoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Eur J Cancer Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Protocolos de Quimioterapia Combinada Antineoplásica / Quinases de Proteína Quinase Ativadas por Mitógeno / Proteínas Proto-Oncogênicas B-raf / Inibidores de Proteínas Quinases / Melanoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Eur J Cancer Ano de publicação: 2021 Tipo de documento: Article